TY  - JOUR
AU  - Marcellusi, Andrea
AU  - Bini, Chiara
AU  - Andreoni, Massimo
AU  - Sarmati, Loredana
AU  - Espin, Jaime
AU  - Horcajada, Juan P
AU  - Czypionka, Thomas
AU  - Andretta, Davide
AU  - Sciattella, Paolo
AU  - Favato, Giampiero
AU  - Mennini, Francesco S
PY  - 2020
DO  - 10.1007/s40261-020-00891-w
UR  - http://hdl.handle.net/10668/15073
T2  - Clinical drug investigation
AB  - Acute bacterial skin and skin structure infections (ABSSSIs) have been defined by the US Food and Drug Administration (FDA) in 2013 to include a subset of complicated skin and skin structure infections commonly treated with parenteral antibiotic...
LA  - en
KW  - Anti-Bacterial Agents
KW  - Budgets
KW  - Costs and Cost Analysis
KW  - Europe
KW  - Hospitalization
KW  - Humans
KW  - Italy
KW  - Skin Diseases, Bacterial
KW  - Spain
KW  - Teicoplanin
TI  - Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries.
TY  - research article
VL  - 40
ER  -